Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 4/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyclohexane SCHEMBL27280449 | 1.00 | ALOX5 (0.37) | ALOX5ALDH1A1LMNAOR51E2TDP1 | |
| Cyclopentane SCHEMBL28068666 | 0.96 | ALOX5 (0.39) | ALOX5ALDH1A1LMNAOR51E2TDP1 | |
| Cyclohexane SCHEMBL27505705 | 0.96 | ALOX5 (0.39) | ALOX5ALDH1A1LMNAOR51E2TDP1 | |
| Ammonia Solution, Strong SCHEMBL27734425 | 0.89 | — | — | |
| SCHEMBL2917853 | 0.84 | — | — | |
| Hydrochloric Acid SCHEMBL28035645 | 0.81 | — | — | |
| SCHEMBL28126805 | 0.81 | — | — | |
| Methane SCHEMBL27588159 | 0.81 | — | — | |
| SCHEMBL28161511 | 0.80 | ALOX5 (0.45) | ALOX5ALDH1A1EPHX1 | |
| Hydrochloric Acid SCHEMBL27661442 | 0.77 | LMNA (0.39) | ALDH1A1LMNAOR51E2TDP1ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106154792-A | Image processing system | 东芝泰格有限公司 | 2016-11-23 | — | — | CN | disclosed |
| CN-102718748-B | There is the compound of analgesic activities and/or Immuno-stimulant activity | 阿勒根公司 | 2016-06-22 | — | — | CN | disclosed |